Antibody Response to DT–GM, a Novel Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT) Linked to Human Granulocyte–Macrophage Colony Stimulating Factor (GM), during a Phase I Trial of Patients with Relapsed or Refractory Acute Myeloid Leukemia

Publication | Closed Access

DOI

Citations

References

2001

Year

Philip D. Hall, Gabriel Virella, Tony E. Willoughby, Daniel H. Atchley, Robert J. Kreitman, Arthur E. Frankel

Clinical Immunology

Hematological MalignancyImmunoengineeringImmune RegulationImmunologyHematologyTumor ImmunityImmune SurveillanceAntibody ResponseImmunomodulationImmunotherapeuticsImmune SystemMedicineCell BiologyTruncated Diphtheria ToxinMyeloid Neoplasia